SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-23-005140
Filing Date
2023-02-15
Accepted
2023-02-15 08:01:17
Documents
15
Period of Report
2023-02-14
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 49004
2 ex99-1.htm EX-99.1 54682
3 ex99-1.jpg GRAPHIC 4867
  Complete submission text file 0001493152-23-005140.txt   349459

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE aeha-20230214.xsd EX-101.SCH 4088
5 XBRL DEFINITION FILE aeha-20230214_def.xml EX-101.DEF 26758
6 XBRL LABEL FILE aeha-20230214_lab.xml EX-101.LAB 36927
7 XBRL PRESENTATION FILE aeha-20230214_pre.xml EX-101.PRE 25382
9 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 5823
Mailing Address 515 MADISON AVE SUITE 8078 NEW YORK NY 10022
Business Address 515 MADISON AVE SUITE 8078 NEW YORK NY 10022 (646) 908-2658
Ocean Biomedical, Inc./DE (Filer) CIK: 0001869974 (see all company filings)

IRS No.: 871309280 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40793 | Film No.: 23633651
SIC: 2834 Pharmaceutical Preparations